Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
China Medical & HealthCare Group Limited(Incorporated in Bermuda with limited liability)
(Stock Code: 383) FURTHER ANNOUNCEMENT DISPOSAL OF SHARES BY A SUBSTANTIAL SHAREHOLDERThis announcement is made by China Medical & HealthCare Group Limited (the "Company") pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
Reference is made to the announcement of the Company dated 18 April 2017 relating to the disposal of shares in the Company by a substantial shareholder (the "Announcement"). Unless otherwise defined, capitalised terms used herein shall have the same meanings as those used in the Announcement.
The Company has been informed by Vigor Online that pursuant to the written notification of closing date issued by the purchaser (the "Purchaser") under the Agreement, on 15 September 2017 (after trading hours), Vigor Online and the Purchaser agreed to designate 18 September 2017 as the date of completion of the sale and purchase of the Sale Shares under the Agreement (the "Completion Date") or such later date as may be further agreed between Vigor Online and the Purchaser, provided that the Completion Date shall be on or before 22 September 2017.
The Company will keep the public informed of the progress of the matter by making further announcement(s) as and when appropriate.
By order of the Board
China Medical & HealthCare Group Limited Dr. Lim Cheok PengChairman
Hong Kong, 15 September 2017
As at the date of this announcement, the board of directors of the Company comprises: -
Executive Directors
Ms. Chong Sok Un (Deputy Chairman), Dr. Jonathan Weiyan Seah (Chief Executive Officer), Dato' Wong Peng Chong and Mr. Kong Muk Yin
Non-Executive Directors
Dr. Lim Cheok Peng (Chairman) and Mr. Liao Feng
Independent Non-Executive Directors
Mr. Lau Siu Ki, Mr. Zhang Jian and Dr. Xia Xiaoning
China Medical & HealthCare Group Ltd. published this content on 15 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 15 September 2017 12:23:05 UTC.
Original documenthttp://www.irwebcast.com/cgi-local/report/redirect.cgi?url=http://www.irasia.com/listco/hk/cmhg/announcement/a170915.pdf
Public permalinkhttp://www.publicnow.com/view/17263BEF4A918FC0D5AE5156BCC541FE7DCCB489